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Chemotaxis, the directional movement towards a chemical compound, is an essential property of many cells and has been linked to the
development and progression of many diseases. Eukaryotic chemotaxis is a complex process involving gradient sensing, cell polarity, remodelling
of the cytoskeleton and signal relay. Recent studies in the model organism Dictyostelium discoideum have shown that chemotaxis does not depend
on a single molecular mechanism, but rather depends on several interconnecting pathways. Surprisingly, small G-proteins appear to play essential
roles in all these pathways. This review will summarize the role of small G-proteins in Dictyostelium, particularly highlighting the function of the
Ras subfamily in chemotaxis.
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Chemotaxis or directional movement towards a chemical
compound is an essential property of many cells [1]. For
example, chemotaxis is critical for the sourcing of nutrients by
prokaryotes, the organization of the embryo in metazoa, the
formation of multicellular structures in protozoa and the
migration of lymphocytes during immune response [2–5].
Chemotaxis is also linked to the development and progression
of many diseases including asthma, arthritis, arteriosclerosis,
and cancers [6–8]. Therefore further insight into the molecular⁎ Corresponding author. Tel.: +31 503634172; fax: +31 503634165.
E-mail address: P.J.M.van.Haastert@rug.nl (P.J.M. van Haastert).
0898-6568/$ - see front matter © 2008 Elsevier Inc. All rights reserved.
doi:10.1016/j.cellsig.2008.02.006mechanism of chemotaxis is important for the understanding of
many biological processes.
Research on eukaryotic chemotaxis has progressed substan-
tially, mainly through the study of neutrophils or the amoeba
Dictyostelium discoideum as model systems [1]. Dictyostelium
is a free-living soil amoeba that feeds on bacteria. They chase
bacteria by chemotaxing towards folic acid, which is secreted
by the bacteria. Upon starvation cells undergo a tightly
regulated developmental process. During development single
cells undergo a drastic change in gene expression and start to
secrete cAMP. Neighbouring cells respond by migrating toward
the chemoattractant cAMP and by secreting cAMP themselves,
resulting in multicellular fruiting bodies. Recently the assembly
of the Dictyostelium genome was completed [9]. The 34 Mb
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higher eukaryotes and are missing in other lower eukaryotes
such as yeast [9]. As the mechanism of chemotaxis is essentially
identical in all eukaryotes, Dictyostelium offers a genetically
tractable model in which to study chemotaxis [1,10].
Chemotaxis is a complex cellular process involving a multi-
tude of signalling pathways and molecules. Eukaryotic chemo-
taxis involves three distinct and separable processes: directional
sensing, cellular motility and cell polarity [1,11]. The first step in
directional sensing is the binding of the chemoattractant to cell-
surface G-protein coupled receptors (GPCRs), which are charac-
terized by seven membrane-spanning α-helices. Upon ligand
binding, GPCRs undergo a conformational change that enables
them to activate heterotrimeric G-protein; by exchanging the
G-protein bound GDP to GTP. This exchange promotes dissocia-
tion of the three subunits as Gα-GTP and a Gβγ dimer, both of
which can regulate a diverse set of downstream effectors. Due to
the intrinsic Gα associated GTPase activity, GTP is hydrolysed to
GDP, and the inactive heterotrimer is formed again [12–14].
In Dictyostelium four cAMP receptors have been identified
(cAR1–cAR4). cAR1–4 are expressed sequentially throughout
development and can all support chemotaxis. Since the types of
cAMP receptor expressed sequentially during development have
decreasing affinities, they are able to cope with an increase in
extracellular cAMP concentration during the aggregation stage
[15,16]. cAR2–4 have a relative low affinity for cAMP and are
important during multicellular stage, whereas cAR1 has a high
affinity for cAMP and is essential for signal transduction during
early development and chemotaxis.Dictyostelium contains one
G-protein β subunit and one Gγ subunit, which are both essential
for chemotaxis. Of the 11 identifiedGα subunits, Gα2 is coupled to
the cAR1 receptor and most important for cAMP-mediated
chemotaxis [17–19], Gα1 is coupled to a yet unidentified CMF
receptor [20] and to cAR1 leading to inhibition of PLC activity [21],
while Gα4 is most likely coupled to a yet unidentified receptors for
folate [20,22]. Disruption of Gα2 results in cells that are unable to
aggregate and do not respond to cAMP stimulation [18], a
phenotype similar to strains deleted in cAR1 and Gβ [18,23,24],
these phenotypes indicate that their function is essential for
directional sensing and chemotaxis. Surprisingly, detailed analysis
of the localisation and dissociation of these upstream components
of the chemotactic signal-transduction machinery has revealed that
cell polarization is established downstream of G-proteins. In cells
exposed to a cAMP gradient, cAR1 is expressed uniformly on the
plasmamembrane [25], as are the G-protein subunits [26,27], while
G-protein activation reflects the shallow external gradient of cAMP
[26]. Subsequently the activated G-proteins convert the signal into
the interior of the cell where they activate a complex network of
signallingmolecules, resulting in a gradient of cellular components.
This gradient induces coordinated remodelling of the cytoskeleton
and cell adhesion to the substratum, which leads to formation of
new actin filaments in the front that induce the formation or
stabilization of local pseudopodia, and acto-myosin filaments that
inhibit pseudopod formation and retract the uropod. The final
outcome is cellular movement up the chemoattractant gradient.
An important response in both the establishment of cell
polarity and chemotaxis is the formation and accumulation ofphosphatidylinositol-3,4,5-triphosphate (PI(3,4,5)P3) at the lead-
ing edge [28–30]. Phosphoinositide 3-kinase (PI3K) produces PI
(3,4,5)P3 by phosphorylation of “PI(4,5)P2", and phosphatase
and tensin homologue deleted on chromosome ten (PTEN)
converts PI(3,4,5)P3 back to PI(4,5)P2. Upon stimulation PI3K is
rapidly translocated and activated at the leading edge, while
PTEN is delocalised from the front to the lateral and posterior
membrane [28–30]. By this reciprocal temporal and spatial
regulation of PI3K and PTEN a PI(3,4,5)P3 gradient is
accomplished. The accumulation of PI(3,4,5)P3 at the leading
edge results in recruitment of PI(3,4,5)P3 binding molecules and
subsequent pseudopod extension [28,30,31]. Although, initial
studies described an essential role for PI3K, recent studies have
shown that chemotaxis does not depend on the PI(3,4,5)P3
pathway [32–34]. Cells with disruption in all five genes encoding
type I PI3Ks still exhibit normal chemotaxis, suggesting that PI
(3,4,5)P3 mediated signalling works in conjunction with one or
more pathways to mediate chemotaxis [33]. Two studies
identified phospholipaseA2 as a chemotactic pathways parallel
to the PI3K pathway [32,34]. Chen et al. described that loss of the
Ca2+-independent phospholipaseA2 (iPLA2) homologue plaA
results in cells that are hypersensitive to the PI3K inhibitor
LY294002 and show dramatically reduced chemotaxis. Consis-
tently, van Haastert et al. showed that inhibition of either PI3K or
PLA2 has minor effects on chemotaxis, whereas inhibition of
both enzymes inhibits chemotaxis nearly completely. The effects
of inhibition of PI3K and PLA2 on chemotaxis are less severe at
later stages of development, suggesting the presence of a third
pathway in longer starved cells. Genetic studies suggest that this
third pathway consists of a soluble guanylyl cyclase [35]. These
data show that chemotaxis does not depend on a single molecular
mechanism but depends on several interconnecting pathways.
Many studies have focused on the signal pathways downstream
of the heterotrimeric G-proteins. Several of these studies have
revealed that an early event in chemotaxis is the activation of small
G-proteins. In this review we will focus on small G-proteins in
Dictyostelium, particularly highlighting the important role of the
Ras subfamily in chemotaxis.
2. Small G-proteins
Small GTPases are monomeric GTP-binding proteins, which
function as molecular switches to control a wide variety of
cellular functions. They switch between an inactive GDP-bound
and active GTP-bound state (Fig. 1). Ras activity is regulated by
guanine nucleotide exchange factors (GEFs) that catalyse the
exchange of GDP for GTP, thereby activating the Ras protein.
GTPase activating proteins (GAPs) stimulate an otherwise low
intrinsic GTPase activity by many orders of magnitude,
reverting the conformation back to the inactive GDP-bound
form [36]. The eukaryotic small GTPase superfamily can be
divided into five major subfamilies: Ras, Rho, Rab, Ran and Arf
[37]. In the genome ofD. discoideum an unusual large amount of
small GTPases were identified. It contains a total of 119 genes
encoding small GTPases, encompassing all five subfamilies
[9,38]. Proteins of the Rab, Ran and Arf subfamilies are mostly
implicated in the regulation of vesicular or nuclear transport,
Fig. 1. Ras signalling. (A) The G-protein cycle. Small G-proteins switch
between an inactive GDP-bound and active GTP-bound state. GEFs (guanine
exchange factors) activate GDP-bound Ras by catalysing the exchange of GDP
for GTP. Only in the active GTP-bound state, Ras can interact with downstream
effectors. GAPs (GTPase activating proteins) catalyse the return to the inactive
GDP-state, by stimulating an otherwise low intrinsic GTPase activity. (B) Ras
activation at the leading edge of chemotaxing cells. Ras activation in vivo
monitored by using GFP tagged RBD of Raf1 (Raf_RBD-GFP), which binds to
and thus visualizes Ras-GTP levels and its localisation. (C) Rap1 activation at
the leading edge of chemotaxing cells. In vivo Rap activation as visualized by
GFP tagged Ras-binding domain (RBD) of RalGDS which binds to and thus
monitors Rap1-GTP levels and its localisation.
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the transduction of extracellular signals [37]. Initially Rho
GTPases were implicated in actin-regulated processes such as
morphogenesis, membrane trafficking and motility; however
more recently Rho has been shown to act in numerous other
pathway as well, including, cytokinesis, apoptosis, tumorigen-
esis and cell cycle progression [39,40]. During chemotaxis, RhoTable 1
Overview of the Dictyostelium Ras subfamily
Effect of disruption Regulators
rasB Not stable
rasC Reduced ACA activation, developmental defects GEFA
rasD Slug phototaxis and thermotaxis defects
rasG Growth, developmental and chemotaxis defects GEFR







rapA Not viable GbpD, RapGAPA
rapB
rapC
rhebGTPases are essential for the organization of myosin and
remodelling of the actin cytoskeleton. Subfamily Ras GTPases
are involved in regulating several cytoplasmic signalling
cascades including cell growth, proliferation, differentiation
and survival [37]. Recent studies, mostly performed in Dic-
tyostelium, have shown the importance of Ras subfamily
members in eukaryotic chemotaxis. During chemotaxis, Ras
proteins are key intermediates in directional sensing, cellular
motility and cell polarity [41].
3. Dictyostelium Ras GTPases
Because of their critical role in human oncogenesis Ras (Ras
sarcoma) proteins have been the subject of intensive research
[42]. The Dictyostelium Ras GTPase subfamily comprises 15
proteins; 11 Ras, 3 Rap and one Rheb related protein [38]. Thus far
six Ras subfamily members have been characterized, and they all
appear to have important roles in cell physiology (Table 1). The first
described Ras gene, rasD, was identified as a gene up regulated in
the prestalk population [43]. Genetic studies have linked RasD to
the regulation of both phototaxis and thermotaxis of multicellular
slugs [44]. Localisation and mutant studies suggest an important
role for RasB in progression through the cell cycle. RasB is
localised in the nucleus except during mitosis/cytokinesis. Mutants
carrying a disruption of the rasB gene are unstable and exhibit
severe growth defects; cells expressing the dominant active RasB
(G12T) show abnormal cytokinesis [45]. Several attempts to
generate stable rasB-null cells failed, suggesting an essential role
for RasB [38,45]. Disruption of rasS results in cells that have
defective growth, impaired endocytosis, are highly polarized and
migrate threefold more rapidly than wild-type cells, suggesting
inappropriate control of the actin cytoskeleton [46,47]. RasC and
RasG are the best characterized Dictyostelium Ras proteins, and
both are activated in response to cAMP [48]. RasG and RasC have
both unique and overlapping functions. RasG regulates cellmotility
and the cytoskeleton during the vegetative state. Both RasC and
RasG are involved in the regulation of the cAMP relay and cAMP-
mediated chemotaxis [49–51]. The only thus far characterized
Dictyostelium Rap subfamily member, Rap1, is involved inEffectors Function
Cell cycle/mitosis
ACA cAMP relay, chemotaxis
Phototaxis, thermotaxis
PI3K, RIP3, GC Motility, cytoskeleton, chemotaxis
Balance between feeding and movement
Phg2 Cell polarity, adhesion, cytoskeleton and motility
Fig. 2. Ras signalling at the leading edge. Binding of cAMP to the cAR1
receptor results through heterotrimeric G-protein signalling to the rapid
activation of GEFs and subsequently Ras at the leading edge. cAMP signal
transduction in early development is partitioned between pathways that use
either RasG (depicted in green) or RasC (depicted in red). RasG and RasC seem
to have both unique and overlapping functions. RasG (indicated in green) is
more important for regulating PIP3 signalling and TORC2 activity and
subsequently essential for cell polarity and actin polymerisation at the leading
edge. RasC on the other hand is more important for ACA activity and hence
cAMP relay. Although, Ras is activated independent of PI3K or actin, a positive
feedback loop (indicated in blue) involving PI(3,4,5)P3 mediated actin
polymerisation, recruitment of additional PI3K to the leading edge, and Ras
activation is important for amplifying the initial signal and stabilizing the
leading edge.
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[52–54]. Multiple attempts to generate rapA-null cells have
failed and antisense rapA mRNA resulted in cells with defects
in growth and viability, suggesting an essential role for RapA in
Dictyostelium [52].
4. Ras signalling at the leading edge
Several studies in Dictyostelium have shown the important
role of Ras in cAMP-mediated chemotaxis. Upon cAMP
stimulation both RasC and RasG are rapidly activated [48].
Both in vegetative cells and in stimulated cells, GFP fused Ras
proteins are uniformly distributed along the membrane [55],
indicating that the localisation of Ras does not change upon
stimulation. Ras activation in vivo can be visualized by a GFP
tagged Ras-binding domain (RBD) of Raf1 (Raf_RBD-GFP),
which binds to and thus monitors Ras-GTP levels and its
localisation [55,56]. Raf_RBD-GFP, which is mainly localised
in the cytosol of non-stimulated cells, rapidly translocates to the
membrane upon global stimulation [55]. When expressed in
chemotaxing cells, Raf_RBD-GFP exclusively localised to the
leading edge (Fig. 1B). Therefore, although Ras proteins are
uniformly distributed along the plasma membrane in chemo-
tactic cells, Ras activation primarily takes place at the leading
edge [55]. More evidence for the important role for Ras in
chemotaxis came from genetic studies.
Disruption of both rasC and rasG results in the total loss of
cAMP-mediated signalling; cells fail to aggregate under all
conditions, have no cAMP relay and fail to exhibit chemotaxis
towards cAMP [49]. These data suggest that all cAMP signal
transduction in early development is partitioned between
pathways that use either RasG or RasC (Fig. 2). The exact
mechanism of RasC and RasG activation is not clear, but
apparently requires functional heterotrimeric G-protein since
cAMP-stimulated Ras activation is absent in mutants lacking
Gβ or Gα2 [48,55]. Since Ras is still activated in cells treated
with the actin-polymerisation inhibitor Latrunclin A, a func-
tional cytoskeleton is not essential for Ras signalling. Loss of
PI3K activity, either through gene knockout or use of the PI3K
inhibitor LY294002, has only mild effect on Ras activation,
indicating that also PI(3,4,5)P3 formation is not necessary for
Ras signalling. Ras activation is catalysed by GEF proteins.
Dictyostelium contains 25 genes encoding putative Ras-GEFs,
five of them have been characterized to some extent [57].
Multiple studies have indicated the important role of Aimless
(AleA or GEFA) in chemotaxis. Disruption of gefA results in
cells defective in aggregation, mainly caused by loss of the cAMP
relay, but cells also have a chemotaxis defect [58]. The gefA-null
phenotype shares some characteristics with rasC-null cells and
some with rasG-null cells [49,50,55], so it remained long unclear
whether the main target of GEFA is RasC or RasG. However, a
recent study by Kae et al. suggests that GEFA is specifically
activating RasC, while Dictyostelium GEFR is involved in
activation of RasG [48].
The best-studied downstream effector of Ras is PI3K. Upon
cAMP stimulation PI3K is recruited to the leading edge and
phosphorylates PI(4,5)P2 to form PI(3,4,5)P3. PI(3,4,5)P3 is avery strong inducer of pseudopod extension and important
for mediating directional sensing [28–30]. PI3K consists of an
N-terminal membrane-targeting region, a RBD, a C2 lipid
binding domain (PI3Ka) and a PI3K catalytic domain (PI3Kc).
The RBD domains of PI3K1 and PI3K2 are required for
chemoattractant-stimulated PI3K activity, but not PI3K translo-
cation [28]. RBD domains have an ubiquity fold and interact
tightly only with the GTP-bound but not with the GDP-bound
conformation of Ras-like proteins [59]. Previous studies have
shown that the RBD of PI3K1 and PI3K2 interact weakly with
RasD and strongly with RasC and RasG [28,48]. More evidence
for a role of Ras in PI(3,4,5)P3 signalling comes from several
genetic studies: rasC-null and rasG-null cells have a strongly
reduced Act/PKB response, a downstream effectors of PI3K,
while cAMP-mediated PI(3,4,5)P3 production is completely
Fig. 3. Ras regulation of myosin-II filaments in chemotaxis. Rap1 regulates
leading edge formation by controlling myosin formation at the leading edge.
Upon cAMP stimulation Rap is rapidly activated at the leading edge. Rap-GTP
binds and activates Phg2, which directly or indirectly phosphorylates MHCKa,
thereby inhibitingmyosin filament formation at the front. In the contrarymyosin-
II filaments are formed at the cortex in the back of moving cells, thereby
preventing the formation of lateral pseudopodia and providing the power to
retract the uropod.Myosin assembly at the back is mainly regulated by PAKa and
the cGMP pathway, both of which are activated by Ras. cAMP-mediated Ras
activations lead, through a yet unknownmechanism, in the rapid activation of the
guanylyl cyclases, sGC (soluble guanylate cyclase) and GCA (guanylyl cyclase
A). The resulting cGMP activates GbpC which mediates myosin in two ways. It
regulates myosin assembly at the back of the cell and secondly it regulates
MLCKa phosphorylation, which promotes myosin motor activity, thereby
enhancing the retraction force of myosin filaments causing the uropod to retract.
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dominant active RasG12V leads to prolonged accumulation of
PI(3,4,5)P3 [55].
Although the initial Ras response is independent of PI3K and
actin polymerisation, some studies have suggested the presence
of a positive feedback loop between F-actin, PI3K and Ras [55].
In vivo studies, using Raf_RBD-GFP of Raf1 to monitor Ras
activation, showed reduced Ras activation at the leading edge of
cells treated with the actin-polymerisation inhibitor Latrunclin
A or PI3K inhibitor LY294002. Furthermore, randomly moving
pten-null cells show multiple and broad patches of active Ras
and PI(3,4,5)P3 from which multiple pseudopodia are extended.
After treatment with Latrunclin A or LY294002, both the
spontaneous Ras activation and PI(3,4,5)P3 accumulation in
pten-null cells are completely abolished. These results indicate
that both PI3K and actin can regulate Ras activation. Since Ras
activation is essential for PI3K activation, the presence of a
positive feedback loop was suggested: Upon cAMP stimulation,
Ras is rapidly activated at the leading edge, independent of
PI3K or actin. Ras activation results in the activation of PI3K,
and subsequently the production of PI(3,4,5)P3 at the leading
edge. A positive feedback loop involving PI(3,4,5)P3 mediated
actin polymerisation, recruitment of additional PI3K to the
leading edge, and Ras activation is important for amplifying the
initial signal and stabilizing the leading edge [55,60].
5. Ras signalling and regulation of cellular motility
The establishment of an intracellular gradient leads to major
changes in the cytoskeleton; actin polymerisation occurs at the
leading edge of the cell, while acto-myosin filaments are formed
at the rear and side of the cell. The new actin filaments establish
new adhesion sites in the front and induce the formation or
stabilization of local pseudopodia. The acto-myosin filaments
inhibit pseudopod formation in the rear and retract the uropod.
In this way coordinated cell movement is achieved. Actin
polymerisation is mediated by the Arp2/3 complex which binds
to the sides of pre-existing actin filaments and produces a
complex network of branched filaments that leads to pseudopod
extension [61]. The regulation of this process involves several
groups of proteins, including the Ras and Rho subfamily of
small G-proteins, WASP (Wiskott–Aldrich syndrome protein),
and WAVE/Scar [62,63].
Regulation of the cytoskeleton at the sites and in the back of
the cell is as important as its regulation at the leading edge. In
moving cells myosin-II filaments are formed at the cortex in the
back and at the sites of cells, thereby preventing the formation
of lateral pseudopods and providing the power to retract the
uropod [64]. In Dictyostelium, myosin assembly seems to be
strictly dependent on the phosphorylation state of the myosin
heavy chain (MHC) [65,66]. Phosphorylation by MHCKs
inhibits filament formation [67,68], whereas dephosphorylation
by protein phosphatase 2A is essential for myosin disassembly
[69]. Phosphorylation of the myosin light chain (MLC) by
MLCKs, promotes myosin motor activity, which is important
for supplying contractile force to retract the rear of the cell
[65,66]. In Fig. 3, a schematic overview of the pathwaysregulating myosin-II filament formation in Dictyostelium is
depicted. Several studies have shown that cGMP is the key
regulator of myosin formation [70]; cells lacking cGMP
formation have an impaired recruitment of myosin-II to the
cytoskeleton, and cells with elevated levels of cGMP have
increased activation of myosin-light-chain kinase A (MLCKa)
and subsequently an increased myosin motor activity.
cGMP is rapidly produced in response to cAMP by the
enzymatic activity of two guanylyl cyclases and its degradation
is performed by three phosphodiesterases [71,72]. Thus far only
one downstream target of cGMP has been identified, the high-
affinity cGMP-binding protein GbpC [73]. GbpC belongs to a
new group of the GTPase superfamily, termed Roc (Ras of
complex proteins), and contains leucine-rich repeats, Roc small
GTPase, kinase, GEF and cyclic nucleotide binding domains
[73,74]. Mutants lacking cGMP or GbpC show greatly reduced
MLCKa activation and subsequently reduced RLC phosphor-
ylation. Probably, cGMP binds to GbpC, thereby increasing its
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either directly or via an intermediate kinase.
Several Ras subfamily members have been linked to the
activation of the cGMP pathway. Cells lacking rasC or rasG have
a reduced cGMP response, while in the rasC/rasG-null mutant
barely any response could be detected, indicating that both RasC
and RasG are important regulators of the cGMP pathway [49].
Consistently, also mutants lacking gefA or the Ras effector rip3
have a strongly reduced cAMP-mediated cGMP response [75].
Also Rap1 is linked to the cGMP pathway; cells depleted in Rap1
have a reduced cGMP response after osmotic shock, while cells
expressing constitutively active Rap1(G12V) show an enhanced
response [52].
Dictyostelium Rap1 is rapidly activated at the leading edge of
chemotaxing cells (Fig. 1C), however with slower kinetics as
those of Ras [76]. Rap1 is an important regulator of cytoskeletal
rearrangement, phagocytosis, adhesion and chemotaxis [52–
54]. Cells expressing dominant negative Rap(S17N) have a
more polar elongated cell morphology and are less adhesive
compared to wild-type cells, whereas cells expressing consti-
tutive active Rap are flat, extend many substrate-attached
pseudopodia, are highly adhesive and have impaired chemo-
taxis [53,76,77]. Consistently, a strikingly similar phenotype
was observed in cells overexpressing the Dictyostelium Rap-
GEF GbpD [78,79]. Dictyostelium GbpD was previously
identified as putative cGMP-binding proteins. GbpD contains
a CDC25-homology domain responsible for mediating GEF
activity, a Ras exchange motif (REM) domain, a GRAM
(glucosyltransferases, Rab-like GTPase activators, myotubalar-
ins) domain and two cyclic nucleotide binding domains, that
appear not to bind cAMP or cGMP [73]. Cells lacking GbpD
display improved chemotaxis and are hyperpolar, because cells
make very few lateral pseudopodia, whereas the leading edge is
continuously remodelled [78,80]. Overexpression of GbpD
results in severely reduced chemotaxis. Cells extend many
bifurcated and lateral pseudopodia, resulting in the absence of a
leading edge. Furthermore, cells are flat and adhesive owing to
an increased number of substrate-attached pseudopodia [78].
Although GbpD contains two cNB domains, it is not regulated
by cAMP or cGMP: Radioactive cyclic nucleotide binding
assays with cells overexpressing GbpD or from Eschericha coli
purified protein revealed no detectable binding of cAMP or
cGMP [80]. In support of these data, the strong GbpDOE
phenotype is independent of the presence of cAMP/cGMP [78].
Since Rap1 appears to be essential in Dictyostelium, whereas
disruption of gbpD is not lethal and gbpD-null cells still contain
active Rap [79], there must be at least one additional GEF
protein for Rap. Besides multiple Rap specific GEFs, as many
as nine putative Dictyostelium rapGAPs have been identified.
Of these rapGAPs, which catalyse the inactivation of Rap, thus
far only rapGAP1 has been characterized [81]. RapGap1
localises at the leading edge with slightly delayed properties as
Rap1-GTP, rapGAP1-null cells have increased and extended
Rap1-GTP activation and a phenotype identical to cells
overexpressing RapG12V or GbpD. These data underline the
important role of Rap in cell adhesion, cell polarity and
chemotaxis [76,79,81].The mechanism by which Rap regulates its functions is not
completely understood, however recent studies provided evi-
dence that Rap1 is involved in inhibition of myosin-II at the
leading edge of Dictyostelium cells [76]. Cells expressing
RapG12V exhibit strongly reduced cAMP-mediated myosin
assembly and are unable to control cell contraction, a phenotype
similar to cells lacking myosin-II [52,66,76]. In a screen for
downstream targets of GbpD/Rap, the serine/threonine kinase
Phg2 was identified as the first Dictyostelium Rap effector [79].
Like many of the mammalian Rap effectors, Phg2 contains a
putative RA domain [82]. By yeast two-hybrid and guanine
nucleotide dissociation measurements it was shown that the RA
domain of Phg2 preferentially binds Rap1-GTP over Ras-GTP
[79,82]. In the contrary to overexpression of GbpD or RapG12V
in wild-type cells, overexpression of GbpD or RapG12V in phg2-
null does not result in increased substrate attachment, indicating
that Phg2 is essential for Rap1 mediated adhesion [79,82]. Upon
cAMP stimulation Phg2 rapidly localises to the leading edge,
extending weakly to the posterior sides, a temporal and spatial
localisation similar to Rap1-GTP [76]. The RA domain of Phg2 is
not necessary for its translocation but is essential for activity [76].
Disruption of phg2 results in impaired chemotaxis, cells have a
broad leading edge, extend multiple pseudopodia and move
slowly [76]. Further study revealed that phg2-null cells have an
increased amount of myosin-II and Phg2 is essential for efficient
myosin-II phosphorylation in vitro [76]. These results suggest that
Rap1 mediates at least partly its functions by controlling myosin-
II assembly and disassembly through Phg2.
Another protein involved in regulation of myosin assembly
is the p21-activated kinase PAKa; pakA-null cells, like cells
deficient in cGMP production, fail to induce cAMP-mediated
myosin association with the cell cortex [83]. The mechanism by
which PAKa regulates myosin assembly is unknown, but does
not involve direct phosphorylation of MHC. In a recent study it
was shown that PI3K and PKB/Akt mediate both the
localisation and activity of PAKa, thereby revealing an
interesting link between the PI(3,4,5)P3 pathway and regulation
of myosin assembly [84]. Therefore PI(3,4,5)P3 formation is
important for both the regulation of pseudopod formation at the
leading edge, as well for regulation of myosin assembly at the
back of the cell.
6. Role of Ras in signal relay
For proper aggregation of Dictyostelium cells, cAMP relay,
the process by which the signal is passed throughout the cell
population, is essential [85]. As mentioned above, upon
starvation Dictyostelium cells enter the developmental stage
eventually resulting in the formation of multicellular fruiting
bodies [86]. Starved Dictyostelium cells produce and secrete
cAMP, which induces its own production by binding to and
activation of the cAR1 receptor, resulting in the activation of
ACA (adenylyl cyclase for aggregation) and cAMP production.
Cells lacking ACA are devoid of chemoattractant-mediated
cAMP production and therefore not able to aggregation [85].
Activity of ACA is regulated by Gβγ and needs in addition two
novel cytosolic regulators: cytosolic regulator of adenylyl
1421A. Kortholt, P.J.M. van Haastert / Cellular Signalling 20 (2008) 1415–1422cyclase (CRAC) and TORC2 [75,87–90]. Upon cAMP
stimulation CRAC transiently translocates to the leading edge,
by binding to PI(3,4,5)P3 through its PH domain. Localisation of
CRAC at the leading edge is required for proper activation of
ACA [91]. Since CRAC localisation depends on PI(3,4,5)P3 and
PI(3,4,5)P3 formation depends on Ras activation, Ras indirectly
regulates ACA activity. Consistently, cAMP-mediated ACA
activation is reduced in pi3k-null cells and rasG-null cells, further
reduced in rasC-null cells and almost absent in rasC/rasG-null
[49,92]. rasC-null and gefA-null cells are unable to aggregate, a
defect which can be recovered by exogenous application of
cAMP pulses [58,93]. Overexpression of CRAC cannot rescue
the gefA-null phenotype, indicating that it is not caused by
decreased CRAC activity [58]. Therefore it seems that the GEFA/
RasC pathway activates a pathway parallel to CRAC that is
essential for ACA activity.
Ras also regulates ACA activity through TORC2. The
Dictyostelium TORC2 complex is formed by Pianissimo (Pia),
RIP3 and LST8 [89]. Similar to crac-null cells, cells lacking pia,
rip3, or lst8 have an severely impaired cAMP response and are
unable to spontaneously aggregate [75,87,89]. Like for rasC-null
and gefA-null, exogenous pulsing with cAMP partly rescues the
rip3-null phenotype, but not the aggregation defects of pia-null
and lst8-null cells [89]. RIP3 was identified in a screen for
proteins that interact withDictyosteliumRas proteins and contains
like many Ras effectors an RBD [75]. RIP3 carrying point
mutations that disrupt binding to Ras-GTP is unable to rescue the
phenotype of rip3-null cells, indicating that Ras is an essential
regulator of TORC2 function [89]. Since RasC seems to be the
primary Ras protein regulating ACA activity and rasC-null and
rip3-null cells have similar defects, it was suggested that RasC
might regulate TORC2 activity [49,75,89]. However, RIP3
interacts better with RasG than with other Dictyostelium Ras
proteins in yeast two-hybrid assays, indicating that RasG might
also be involved in regulation of TORC2 and ACA activity [75].
In addition to its putative role in ACA activation, evidence has
been obtained suggesting that RasG is also a negative regulator of
ACA activity. Cells expressing constitutively activated RasG
(G12T) are defective in cAMP production and unable to
aggregate [94]. Overexpression of constitutively activated RasG
(G12T) severely inhibits ERK2 activation in response to both
cAMP and folic acid [95], a response that is essential for ACA
activation [96,97].
Although the pathways regulating ACA activity have only
been partly characterized, Ras proteins are clearly important
regulators of the cAMP relay.
7. Conclusion
Chemotaxis is a complex process involving gradient sensing,
cell polarity remodelling of the cytoskeleton and signal relay.
Surprisingly, Ras proteins appear to play essential regulatory
roles in all these processes. Although knowledge about the
function of Ras proteins has progressed quickly over the past
few years, still many questions have to be addressed. So far only
six Ras proteins have been characterized, only few Ras effectors
have been identified and the temporal and spatial modulation ofRas activity through GEFs and GAPs is not well understood.
Since Ras proteins are key mediators of chemotaxis, addressing
these questions will greatly contribute to the understanding of
chemotaxis.
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